Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

India · Delayed Price · Currency is INR

127.93

-0.48 (-0.37%)

At close: Jun 17, 2026

6.61% (1Y)

Market Cap	10.09B
Revenue (ttm)	820.13M +1,617.8%
Net Income	154.97M +804.1%
EPS	2.49 +408.5%
Shares Out	78.84M
PE Ratio	51.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	181,206
Open	128.75
Previous Close	128.41
Day's Range	127.00 - 130.39
52-Week Range	98.36 - 148.34
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limit... [Read more]

Industry Hospitals

Founded 2014

Employees 338

Stock Exchange National Stock Exchange of India

Ticker Symbol GKSL

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:GKSL's revenue was 820.13 million, an increase of 103.80% compared to the previous year's 402.42 million. Earnings were 154.97 million, an increase of 64.63%.

Financial Statements